What Innopsys does

Innopsys is a French scientific-instrument manufacturer founded in 1999 and headquartered in Carbonne, France, that designs, manufactures, and sells fluorescence detection systems and associated software for biotechnology and medical research laboratories. Its product portfolio is organized around two proprietary technology lines: the InnoScan microarray scanner family — launched in 2006 and including the InnoScan 710 (visible 2-color), InnoScan 710-IR (near-infrared), and InnoScan 1100 (3-color confocal with autoloader) — and the InnoQuant fluorescence slide scanner launched in 2023 that extends line-scanning architecture into tissue multiplexing and whole-slide immunocytochemistry imaging. Both product families share a laser-illuminated, photomultiplier-based line-scanning detection platform, with MAPIX software providing acquisition and quantification, and outputs are compatible with mainstream analysis environments (QuPath, Fiji, HALO). Key technical differentiators include single-pass acquisition that eliminates tiling and stitching artifacts, simultaneous 4-channel fluorescence detection with 98% field uniformity, dynamic content-based focusing, and patented XY motorisation enabling 10–35 lines per second scanning speed. The company is ISO 13485:2016 certified for medical-device quality management since 2009 and reinvests roughly 30% of turnover annually into R&D.

The business model is hardware-centric: scientific instruments are sold to academic and private research laboratories, hospitals, and biotech companies, with recurring revenue from technical support, preventive maintenance, installation, and training services. Pricing is quote-based rather than publicly disclosed. Go-to-market combines a worldwide distribution network covering more than 50 countries with a wholly-owned US commercial subsidiary (Innopsys Inc, Chicago) for direct North American sales and support, complemented by remote and on-site technical support through local partners. The customer base spans life-science research (proteomics, glycomics, genomics, drug discovery), clinical diagnostics and translational research, and neuroscience/CNS imaging — anchored by reference users such as Utrecht University and Utrecht Institute for Pharmaceutical Sciences. Innopsys is a privately held, founder/management-led French SAS (Stéphane Le Brun, CEO) with no disclosed external funding rounds, a small SAS capital base, and a multidisciplinary team of scientists and engineers specializing in optics, micromechanics, electronics, computing, nanotechnology, and biology; all manufacturing occurs on the Carbonne site.

Name

Innopsys

Legal name

INNOPSYS SAS

Website

https://innopsys.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Innopsys is a French scientific-instrument manufacturer, founded in 1999 and based in Carbonne, that designs and produces fluorescence detection scanners — the InnoScan microarray line and the InnoQuant tissue slide scanner — together with MAPIX acquisition software, serving biotech, pharmaceutical, clinical, and academic research laboratories in more than 50 countries.

Ownership category

akta.pro rank

Product category

Scientific Imaging Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

akta.pro secondary industries

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

Keywords

• Microarray scanners
• Fluorescence slide scanners
• Tissue imaging instruments
• Biotech lab equipment
• Scientific imaging devices

Headquarters

HQ city

Carbonne

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Scientific instrumentation hardware sales: Innopsys designs, manufactures and sells scientific instruments including microarray scanners (InnoScan series) and fluorescence slide scanners (InnoQuant). Products are sold to research laboratories, hospitals and biotech companies globally.
2. Technical support and maintenance services: Technical customer support including preventive maintenance, one-off maintenance, remote diagnostics, installation and training services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Innopsys designs, manufactures, and sells fluorescence-based scientific instruments and associated software for biotechnological and medical research laboratories. Its portfolio includes the InnoScan series of microarray scanners (InnoScan 710, InnoScan 710-IR, InnoScan 1100) for proteomics, glycomics and genomics applications, and the InnoQuant tile-free whole-slide fluorescence scanner for tissue multiplexing and immunocytochemistry. The MAPIX image acquisition and spot quantification software complements the hardware offering.

Product overview

Innopsys offers two distinct product lines for fluorescence-based biological imaging: the InnoScan microarray scanner series (launched 2006) for genomic and proteomic applications, and the InnoQuant fluorescence slide scanner (launched 2023) for tissue multiplexing. The InnoScan series includes the InnoScan 710 (2-color, visible spectrum), InnoScan 710-IR (infrared, 2-color), and InnoScan 1100 (3-color confocal) models. These microarray scanners are complemented by MAPIX acquisition and analysis software. InnoQuant represents the company's expansion into tissue imaging, featuring single-pass, tile-free whole-slide acquisition with 4-channel simultaneous detection and compatibility with standard analysis tools like QuPath, Fiji, and HALO.

Differentiator

Problem solved

Functional benefit

Brands

• InnoScan: Series of microarray scanners for fluorescence detection used in genomics, proteomics, and various life science applications.
• InnoQuant
• MAPIX

Products and services

• InnoQuant Fluorescence Slide Scanner Quantitative fluorescence slide scanner for tissue multiplexing using single-pass acquisition to capture whole-slide images without tiling, stitching, or shading correction. Features 4-channel simultaneous detection (375nm UV, 488nm, 555nm, 640nm) with 0.5 µm/pixel resolution equivalent to 20x magnification, delivering artifact-free images in a single field of view with 98% uniformity. Targeted at research and clinical laboratories performing biomarker quantification and multiplex tissue analysis.
• InnoScan 1100 Microarray Scanner A 3-color ultra-high resolution microarray scanner with 0.5 µm pixel size (20x microscope magnification), featuring confocal detection with 3 analog PMTs, real-time autofocus, and a 24-slide autoloader (AL version) for high-throughput applications. Compatible with standard microscope slides and various fluorophores (Cy2/3/5, Alexa Fluor series). Targeted at genomics, proteomics and high-throughput microarray workflows in research laboratories.
• InnoScan 710-IR Microarray Scanner An infrared microarray scanner featuring dual laser wavelengths (670nm, 785nm) with confocal detection using 2 PMTs, capable of scanning slides at 10 µm/pixel in less than 4 minutes. NIR detection dramatically decreases background issues from nitrocellulose supports, improving sensitivity for protein interaction assays. Ideal for routine microarray reading and protein array applications.
• InnoScan 710 Microarray Scanner A two-color microarray scanner with laser excitation at 532nm and 635nm, featuring patented XY motorization for fastest scanning on the market (10-35 lines/second). Capable of reading medium density microarrays at 3 µm/pixel maximum resolution with barcode reader for traceable results. Targeted at research laboratories performing routine DNA and protein microarray reading.
• MAPIX Software Image acquisition and spot quantification software used with InnoScan microarray scanners and InnoQuant fluorescence slide scanners. Enables automated image acquisition and multi-channel image analysis, with multiresolution TIFF outputs compatible with QuPath, Fiji, and HALO. Targeted at laboratories running microarray and tissue imaging experiments.

Quantifiable outcome

• 98% field uniformity across entire slide
• +5 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature7 records

Partnerships

Five partnerships are on record, tiered core and minor.

• SmartCatchcoreStrategic or Co-development Partner · 16 June 2026Collaborative development of integrated liquid biopsy workflow combining SmartCatch's X-Tracker technology with InnoQuant scanner for CTC and CAC detection. Joint application note released showcasing workflow from cell capture to imaging and open-source analysis.
• Utrecht UniversitycoreStrategic or Co-development Partner · 1 June 2026Long-term collaboration with Robert de Vries' lab at Utrecht University for influenza virus research. Lab serves as early adopter of InnoScan series and now InnoQuant for glycan receptor studies and tissue imaging.
• Translucence BiosystemscoreStrategic or Co-development PartnerCollaboration on comparison study of InnoQuant vs widefield microscopy for CNS cells quantification. Translucence provides AI-driven quantification analysis using InnoQuant images for microglial inflammation studies.
• GdR Imabio (Groupement de Recherche)minorStrategic or Co-development PartnerInnopsys became partner of GdR Imabio, a French research network dedicated to promoting collaboration and innovation in advanced bioimaging techniques for life sciences.
• ParalabcoreChannel Partner/ Reseller/ DistributorSpanish distribution partner representing Innopsys at FENS Forum 2026 conference in Barcelona.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Li-Cor Biosciences: Li-Cor manufactures Odyssey and Aeris infrared/near-infrared fluorescence imaging systems and microarray scanners that directly overlap with Innopsys' InnoScan 710-IR product line, especially for nitrocellulose-based protein microarrays and membrane imaging.
• Molecular Devices (Danaher): Molecular Devices offers GenePix microarray scanners and high-content imaging platforms that compete with Innopsys' InnoScan series for genomic/proteomic array readout and with fluorescence imaging workflows more broadly.
• Akoya Biosciences: Akoya Biosciences' PhenoCycler/CODEX and Phenoptics multiplex tissue imaging platforms are the most direct competitors to Innopsys' InnoQuant for spatial biology, multiplex immunofluorescence and quantitative biomarker imaging in tissue.
• Hamamatsu Photonics: Hamamatsu produces NanoZoomer whole-slide scanners and high-sensitivity fluorescence imaging systems used in digital pathology and tissue imaging, competing with InnoQuant on slide-scanning throughput and quantitative fluorescence capability.

Broad incumbents

• Leica Microsystems (Danaher): Leica's Aperio GT and STELLARIS confocal/TIRF systems cover whole-slide scanning and high-end fluorescence microscopy, making Leica a broad incumbent whose instruments overlap with both Innopsys' microarray scanners and tissue-imaging workflows.
• ZEISS (Carl Zeiss Microscopy): ZEISS offers Axio Scan.Z1 whole-slide scanners and a broad portfolio of fluorescence/confocal microscopes, competing with Innopsys across both microarray readout (via research microscopy) and tissue/multiplex fluorescence imaging.
• Thermo Fisher Scientific: Thermo Fisher's life-sciences instrumentation portfolio — including fluorescence imagers, microarrays and high-content screening systems — competes broadly with Innopsys across genomics, proteomics and translational tissue imaging.
• Bio-Rad Laboratories: Bio-Rad supplies Protein Microarray and imaging-related life-science instruments, and its broader analytical workflow tools (ChemiDoc, etc.) overlap with Innopsys' fluorescence and protein-array use-cases in research labs.
• Revvity (formerly PerkinElmer Life Sciences): Revvity offers a broad life-sciences instrumentation portfolio including microarray scanners and high-content imaging platforms that overlap with both Innopsys' microarray and tissue-imaging product lines.

Emerging players

• Standard BioTools (formerly Fluidigm): Standard BioTools provides mass cytometry and imaging mass cytometry (Hyperion) systems for highly multiplexed tissue analysis, competing with Innopsys' InnoQuant in translational tissue-biomarker applications from an emerging-player position.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/innopsys

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innopsys